GLOW 70mg (GHK-Cu + BPC-157 + TB-500)
Original price was: 79,99 €.63,99 €Current price is: 63,99 €.
GLOW Blend Europe GHK-Cu + BPC-157 + TB-500 Research Blend
GLOW Blend Europe is supplied by Baltic Peptides as a three-peptide research blend — GHK-Cu, BPC-157 and TB-500 (thymosin β4) — pre-mixed in a single 70 mg lyophilised vial. Each component is ≥99% pure by HPLC, and every batch of the blend is independently verified by HPLC and mass spectrometry with a batch-specific COA. The GLOW blend brings together three of the most studied peptides in tissue repair and skin research.
Each component works through a different route. GHK-Cu regulates extracellular matrix and collagen synthesis, BPC-157 is studied for angiogenesis and repair of tendon, gut and vascular tissue, and TB-500 binds actin to support cell migration. Combining them lets GLOW Europe researchers look at matrix remodelling, blood-vessel growth and cell movement in the same model.
Supplied exclusively for in vitro and preclinical research by qualified investigators and licensed research institutions.
Third-Party Verified · COA Available · EU Dispatch
Purity — Per Component
Single 70 mg Vial
Key Features
Researchers choosing GLOW Blend Europe from Baltic Peptides receive an independently tested three-peptide blend, each component ≥99% by HPLC, dispatched from within the EU.
-
Purity — ≥99% per component by HPLC
-
Format — Single 70 mg lyophilised vial containing all three peptides
-
Storage (long-term) — −20 °C, desiccated, protected from light
-
Storage (short-term) — 2–8 °C, up to 4 weeks
-
Solubility — Sterile water or bacteriostatic water
-
Classification — Research Use Only (RUO)
-
Testing — Independent third-party verification per batch
-
Documentation — Batch-specific COA for the blend
Scientific Overview — GLOW Blend Europe
Compound Background
Why These Three Peptides
Tissue repair depends on several processes happening together: cells must migrate into the wound, new blood vessels must form, and the extracellular matrix must be rebuilt and remodelled. Each GLOW component has been studied mainly in one of these areas, so the combination covers more of the repair process than any one alone.
GHK-Cu is a naturally occurring copper tripeptide linked to collagen, elastin and glycosaminoglycan synthesis. BPC-157 is a 15-residue fragment of a gastric protein studied for angiogenesis and nitric-oxide signalling. TB-500 is synthetic thymosin β4, a 43-residue peptide that sequesters G-actin and promotes cell migration. Most evidence for all three is preclinical, and the combination itself has not been studied in controlled trials.
The Three Components
| Parameter | GHK-Cu | BPC-157 | TB-500 (T?4) |
|---|---|---|---|
| Size | Tripeptide + Cu²⁺ | 15 aa | 43 aa, N-acetylated |
| Molecular weight | ≈402 g/mol (complex) | 1419.5 g/mol | 4963.5 g/mol |
| Primary research role | Matrix & collagen | Angiogenesis & repair | Actin binding & migration |
| Natural origin | Human plasma peptide | Gastric juice protein fragment | Ubiquitous intracellular peptide |
Primary Research Domains
Mechanisms — Research Context
GLOW
Matrix Gene Expression
Angiogenesis · NO Signalling
G-Actin Binding · Migration
Multi-Pathway Tissue Repair
Technical Specifications — GLOW Blend Europe
| Parameter | Specification |
|---|---|
| Product | GLOW Blend — GHK-Cu + BPC-157 + TB-500 |
| Format | Single lyophilised vial, 70 mg total |
| Component amounts | As stated on the vial label and batch COA |
| GHK-Cu | Gly-His-Lys copper(II) complex · ≈402 g/mol · CAS 89030-95-5 |
| BPC-157 | GEPPPGKPADDAGLV · C62H98N16O22 · 1419.5 g/mol · CAS 137525-51-0 |
| TB-500 (thymosin β4) | Ac-SDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGES · C212H350N56O78S · 4963.5 g/mol · CAS 77591-33-4 |
| Purity | ≥99% per component (HPLC); blend verified per batch |
| Form / Appearance | Pale blue to blue lyophilised powder (colour from GHK-Cu) |
| Solubility | Sterile water or bacteriostatic water (≥1 mg/mL) |
| Long-Term Storage | −20 °C, desiccated, protected from light |
| Short-Term Storage | 2–8 °C, sealed vial, up to 4 weeks |
| Reconstituted Stability | Up to 14 days at 2–8 °C, light-protected; avoid freeze-thaw cycling |
| Research Classification | Research Use Only (RUO) |
| Supplier | Baltic Peptides — EU dispatch from Lithuania |
GLOW Blend Europe — Lab Testing & Quality Assurance
Each batch is independently tested before release and published per lot on our COA page.
HPLC Purity Analysis
Reverse-phase HPLC resolves the three components in the blended material and profiles impurities.
Mass Spectrometry
ESI-MS confirms each identity: GHK (340.4 Da) with bound copper, BPC-157 (1419.5 Da) and thymosin β4 (4963.5 Da).
Batch COA
One batch-specific COA covers the blend, matched to the lot code printed on the vial.
Third-Party Verification
Analytical data is generated by independent external laboratories for auditable, conflict-free documentation.
Storage & Handling — GLOW Blend Europe
A blend is only as stable as its least stable component. TB-500’s single methionine is oxidation-sensitive, and GHK-Cu’s copper should be kept away from chelators and strong acids, so the whole vial is kept cold, dry and dark. See our cold-chain storage guide.
Lyophilised (Unopened)
−20 °C, desiccated. Stable for 24 months from manufacture. Protect from light and moisture.
Short-Term (Unopened)
2–8 °C for up to 4 weeks in the sealed vial.
Reconstituted Solution
2–8 °C, closed and light-protected. Use within 14 days. Avoid freeze-thaw cycling.
Reconstitution
Reconstitute the whole vial in one solvent, adding it slowly down the vial wall and swirling gently — do not vortex. A blue tint from GHK-Cu is normal. Method as in our peptide reconstitution guide.
Related Research Reading
Further reading from the Baltic Peptides Research Library:
Research Use Only — Important Notice
All products supplied by Baltic Peptides are designated exclusively for in vitro research, preclinical investigation, and laboratory study by qualified professionals operating within appropriately licensed or regulated research environments.
The GLOW Blend peptides are not approved for human or veterinary use by any medicines regulator and are not intended for self-administration, clinical application, or any use outside controlled scientific research.
By completing a purchase, the buyer confirms their status as a qualified researcher and acknowledges the research-use-only classification of this product. Baltic Peptides assumes no liability for any use beyond its stated research designation.
Frequently Asked Questions — GLOW Blend Europe
What is the GLOW blend?
GLOW is a three-peptide research blend of GHK-Cu (copper tripeptide), BPC-157 (a 15-residue gastric peptide fragment) and TB-500 (thymosin β4), pre-mixed in one 70 mg lyophilised vial. Each component is ≥99% pure by HPLC.
Is GLOW one vial or three?
One. All three peptides are pre-mixed in a single 70 mg lyophilised vial, so the whole vial is reconstituted at once. For single-compound control arms, use separate GHK-Cu, BPC-157 and TB-500 vials.
Why are these three peptides combined?
They act on different parts of tissue repair: GHK-Cu on matrix and collagen, BPC-157 on angiogenesis and vascular repair, and TB-500 on actin-driven cell migration.
What is the difference between GLOW Europe and KLOW?
KLOW contains the same three peptides plus KPV, an α-MSH-derived tripeptide studied in inflammation models.
Is a Certificate of Analysis available for GLOW Blend Europe?
Yes. A batch-specific COA for the blend documents HPLC analysis of the components, mass spectrometry identity, lot number and testing dates, published on the Baltic Peptides COA page.
What are the shipping conditions for GLOW Blend Europe?
If you buy GLOW Europe, it ships from Lithuania, giving shorter transit times and no non-EU customs exposure for European researchers. Orders are packed with temperature- and light-protective materials and fully tracked. See our shipping page.






